medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2016, Number 5

<< Back Next >>

Acta Pediatr Mex 2016; 37 (5)

Low free triiodothyronine levels in mexican pediatric population with congenital heart disease after cardiac surgery undergoing cardiopulmonary bypass

Araujo MA, García-Benítez L, Hernández BE, Pérez JF, Diliz NH, Tamariz-Cruz O, Palacios Macedo-Quenot A

Language: English
References: 18
Page: 254-259
PDF size: 508.04 Kb.


ABSTRACT

Background: Low free triiodothyronine level in patients undergoing heart surgery with cardiopulmonary bypass (CPB) is well described in literature, but the prevalence in pediatric Mexican population is yet unknown.
Objetive: To know the prevalence of postoperative low free triiodothyronine level and the associated complications after cardiopulmonary bypass exposure in pediatric population in Mexico.
Material and Method: A sample of free triiodothyronine (FT3) blood was obtained in the early postoperative period of patients undergoing CPB heart surgery. Postoperative low FT3 level (PLFT3) was defined as any blood value under 2.9 pg/mL. Logistical regression models were used for analysis of independent variables, adjusted for complexity score (RACHS-1) and Aristotle Comprehensive Complexity Score.
Results: PLFT3 was present in 35.7% of the patients (n=109). Correlation with PLFT3 the following variables were observed: prolonged CPB time (p=0.001) prolonged aortic cross clamp (p=0.002) level of complexity of the surgery as measured by Aristotle ≥3 (p=0.001) and RACHS-1 ≥3 (p=0.021). Associated complications were: postoperative arrhythmias (p=0.008) extended intubation period (p=0.008) and higher infection rate (p=0.002).


REFERENCES

  1. Secretaría de Salud. Dirección General de Información en Salud. Estadísticas: Principales causas de mortalidad infantil y en edad preescolar. México 2008.

  2. Ranasinghe AM, Bonser RS, Thyroid hormone in cardiac surgery. Vascular Pharmacology. 2010;52(3-4):131-7. doi: 10.1016/j.vph.2009.11.004.

  3. Eggum R, Ueland T, Molines T, Videm V, Fiane A, Aukrust P, et.al. Perfusion temperature, thyroid hormones an inflammation during pediatriccardiac surgery. Inter Card Thor Surg 2010;(10):76–80. doi: 10.1510/icvts.2009.213876.

  4. Trimarchi T. Endocrine Problems in Critically Ill Children. AACN ClinicalIssues. 2006;17(1); 66-78.

  5. Talwar S, Khadgawat R, Sandeep JA, Sreenivas V, Choudhary SK, Gupta N, et.al. Cardiopulmonary Bypass and serum Thyroid Hormone Profile in Pediatric Patients with Congenital Heart disease. Congenit Heart Dis. 2012;7(5):433-40. doi: 10.1111/j.1747-0803.2012.00667.x.

  6. Plumpton K, Haas N. Identifying infants at Risk of Marked Thyroidsuppression post cardiopulmonary bypass. Intensive Care Med. 2005;(4):581-587.

  7. Portman MA, Fearneyhough C, Ning XH, Duncan BW, Rosenthal GL, Lupinetti FM. Triiodothyroninerepletion in Infants During Cardiopulmonary Bypass for Congenital Heart Disease. J Thorac Cardiovasc Surg. 2000;120(3):604- 8.

  8. Shih JL, Agus MS. Thyroid Function in the Criticallyi ll Newborn and Child. Curr Opin Pediatr. Aug 2009;21(4):536-40. doi:10.1097/MOP.0b013e32832cbc12.

  9. Bartkowski R, Wojtalik M, Korman E, Sharma G, Henschke J, Mrówczynski W. Thyroid Hormones levels in Infants During and After Cardiopulmonary Bypass with Ultrafiltration. Eur J Cardiothorac Surg 2002;22(6):879-84.

  10. Ravishankar C, Tabbutt S, Wernovsky G. Critical Care in cardiovascular Medicine. Curr Opin Pediatr 2003;15:443–453.

  11. Rakhi B, Suresh G, Sunil S, Balu V, R Krishna K. Dedicated pediatric cardiac intensive care unit in a developing country: Does it improve theout come? Ann Pediatr Cardiol. 2011;4(2):122–126. doi:10.4103/0974-2069.84648.

  12. Amit Varma. Pediatric Cardiac Intensive Care Units: The way Forward. Ann Pediatr Cardiol. 2011;4(2):127–128.

  13. Reichert M, Verzino K. Triiodothyronine Supplementation in Patients Undergoing Cardiopulmonary Bypass. Pharmacotherapy 2001;21(11):1368- 1374.

  14. Portman M., Slee A., Olson A., et al. Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC). Circulation 2010;122(11Suppl):S224-S233. doi:10.1161/CIRCULATIONAHA. 109.926394.

  15. Hass N., Camphausen C., Kececioglu D. ClinicalReview: Thyroid hormone replacement in children after cardiacsurgery– isitworth a try? Crit Care 2006;10(3):213.

  16. Bettendorf M., Schmidt K., et al. Triiodothyroninetreatment in children after cardiac surgery: a double– blind, randomised, placebo –controlled study. Lancet. 2000;356(9229):529-34.

  17. Choy Y., Kwak Y., et al. Peri-operative oral triiodothyronine replacement therapy to prevent post operative low triiodothyronine state following valvular heart surgery. Anesthesia 2009;64:871-877. doi:10.1111/j.1365- 2044.2009.05984.x.

  18. Marwali E, Boom C. Oral Triiodothyronine normalizes triiodothyronine levels after surgery for pediatric congenital heart disease. Pediatr Crit Care Med 2013 Sept 14;(7):701- 708. doi:10.1097/PCC.0b013e3182917f87




2020     |     www.medigraphic.com